This study innovatively integrated bioinformatics analysis with animal experimental validation, identifying CPD, GGCT, SUZ12, and ZMYM2 as shared diagnostic biomarkers for CHD and T2D. This evidence concerns the gene ZMYM2 and type 2 diabetes mellitus.